PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsSERB
SERB(RBA)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Amifampridine serbAmifampridine2022-05-192032-2037
Neoplasms
,
Immune system diseases
,
Autoimmune diseases
,
Nervous system diseases
,
Paraneoplastic syndromes
,
Autoimmune diseases of the nervous system
,
Nervous system neoplasms
,
Neuromuscular junction diseases
,
Neurodegenerative diseases
,
Lambert-eaton myasthenic syndrome
,
Neuromuscular diseases
,
Nervous system paraneoplastic syndromes
AmversioBetaine anhydrous2022-05-05
Homocystinuria
CyanokitHydroxocobalamin2007-11-23
Multiple sclerosis
,
Diabetic neuropathies
,
Alcoholic neuropathy
,
Poisoning
,
Pernicious anemia
Firdapse (previously zenas)Amifampridine2009-12-232032-2037
Neoplasms,
Immune system diseases,
Autoimmune diseases,
Nervous system diseases,
Paraneoplastic syndromes,
Autoimmune diseases of the nervous system,
Nervous system neoplasms,
Neuromuscular junction diseases,
Neurodegenerative diseases,
Lambert-eaton myasthenic syndrome,
Neuromuscular diseases,
Nervous system paraneoplastic syndromes
VoraxazeGlucarpidase2022-01-11
Metabolic side effects of drugs and substances
XermeloTelotristat ethyl2017-09-17
Neuroendocrine tumors,
Carcinoid tumor,
Diarrhea,
Malignant carcinoid syndrome
Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use